Gabelli & Co Investment Advisers’s Kindred Healthcare KND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-468,045
Closed -$4.21M 205
2018
Q2
$4.21M Buy
468,045
+96,014
+26% +$860K 0.52% 46
2018
Q1
$3.4M Buy
372,031
+152,331
+69% +$1.41M 0.43% 45
2017
Q4
$2.13M Buy
219,700
+173,937
+380% +$1.29M 0.28% 57
2017
Q3
$311K Buy
45,763
+1,810
+4% +$15.4K 0.04% 132
2017
Q2
$512K Buy
+43,953
New +$433K 0.06% 117
2015
Q4
Sell
-10,000
Closed -$158K 186
2015
Q3
$158K Hold
10,000
0.02% 154
2015
Q2
$203K Hold
10,000
0.03% 156
2015
Q1
$238K Buy
+10,000
New +$203K 0.04% 132

Gabelli & Co Investment Advisers's KND Position: Q3 2018 in Review

Gabelli & Co Investment Advisers sold out of Kindred Healthcare (KND) in Q3 2018, closing a stake of 468,045 shares — an estimated $4.21M sold.

Gabelli & Co Investment Advisers first reported a position in KND in Q1 2015 and held it in 8 quarters. The position peaked at $4.21M in Q2 2018. 0 funds tracked by Wall St. Rank hold KND as of Q3 2018.

  • Gabelli & Co Investment Advisers reported no remaining Kindred Healthcare position as of Q3 2018 after selling out during the quarter.
  • Gabelli & Co Investment Advisers sold 468,045 Kindred Healthcare shares in Q3 2018, an estimated $4.21M.
  • Gabelli & Co Investment Advisers first reported a position in Kindred Healthcare in Q1 2015 and held it in 8 quarters.
  • Gabelli & Co Investment Advisers's Kindred Healthcare position peaked at $4.21M in Q2 2018.
  • 0 funds tracked by Wall St. Rank held Kindred Healthcare as of Q3 2018.

Based on Gabelli & Co Investment Advisers's 13F filing for Q3 2018, filed 2 Nov 2018.